Real-World Off-Label Use of Semaglutide for Weight Reduction: User Behavior, Effectiveness, and Satisfaction
Off-label Ozempic use in Arab populations is characterized by widespread self-initiation, irregular dosing, and early discontinuation. Nonetheless, clinically meaningful weight loss was achieved in many users. These findings emphasize the need for structured counseling to optimize outcomes.
Authors
- Ayman M. Al‐Qaaneh (ORCID: https://orcid.org/0000-0002-6342-6573)
- Eyad Qunaibi (ORCID: https://orcid.org/0000-0003-0648-0757)
- Natalia A Al-Fraihat
- Baraa E Abu-Aisheh
- Sameh Rabea
- Adnan A Al Aloul
- Rajaa Matahen
- Firas Annabi
Institutions
- Alfaisal University (SA)
- Hashemite University (JO)
- Water Authority of Jordan (JO)
- Al-Balqa Applied University (JO)
- Riyadh Elm University (SA)
- TQ Pharma (Jordan) (JO)
- Islamic Hospital (JO)
- Bioterra University Bucharest (RO)
- King Abdullah Medical City (SA)
Publication Details
- Journal
- Patient Preference and Adherence
- Published
- 2025-10-31
- DOI
- https://doi.org/10.2147/ppa.s549716
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00